22157.jpg
Western Europe Consumer Health Market: UK Adds the Most New Sales, Boosted by Self-Medication and Rx-to-OTC Switches
April 23, 2024 04:28 ET | Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Consumer Health in Western Europe" report has been added to ResearchAndMarkets.com's offering. While coughs, colds and the flu were less prevalent...
lumos.png
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
April 18, 2024 16:05 ET | Lumos Pharma, Inc.
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...
images.png
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
April 18, 2024 07:30 ET | Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at ESCMID Global (Formerly ECCMID)
VMR Logo.png
Astaxanthin Market size worth $ 92.81 Billion, Globally, by 2031 at 2.38% CAGR – Report By Verified Market Research®
April 16, 2024 10:15 ET | Verified Market Research
Jersey City, New Jersey, April 16, 2024 (GLOBE NEWSWIRE) -- The Global Astaxanthin Market is projected to grow at a CAGR of 2.38% from 2024 to 2031, according to a new report published by Verified...
22157.jpg
Asia Pharmaceutical Directory 2024: Top Source of Information on 10,000 Pharmaceutical and Biotechnology Companies
April 15, 2024 11:19 ET | Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Asian Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.Keep up-to-date with the Asian Pharmaceutical...
22157.jpg
Global Pharma Handbook 2024: Expanded Coverage of Health Systems, Sales, Demand Profiles, Clinical Trials, Drug Approval Procedures, Regulatory Policies, IP, Pricing, Marketing, Generics
April 15, 2024 09:06 ET | Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Pharma Handbook 2024" directory has been added to ResearchAndMarkets.com's offering.The Global Pharma Handbook includes expanded coverage of...
22157.jpg
European and USA Pharmaceutical Directory 2024: Indispensable Guide for Key Decision-makers
April 15, 2024 09:04 ET | Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "European and USA Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.The European & USA Pharmaceutical...
22157.jpg
Global Directory Unveils Top 1,000 Pharmaceutical and Biotechnology Companies for 2024
April 15, 2024 09:02 ET | Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Major Pharmaceutical Companies 2024" report has been added to ResearchAndMarkets.com's offering. In an era of rapid technological advancements and...
OptimiTM-03.jpg
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
April 15, 2024 08:00 ET | Optimi Health Corp.
Optimi announces completion of three batches of its MDMA API manufactured from raw materials under the Company’s Precursor Licence.
Sanofi new_logo.jpg
Sanofi: Information concerning the total number of voting rights and shares - March 2024
April 12, 2024 14:05 ET | Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...